Patel Kinnari — SEC Form 4 filings
SEC reporting owner CIK 1725929. 10 Form 4 filings on record with FilingPulse; latest filed 2025-05-22.
Transaction summary — filings shown
Covers all 10 filings on record, filed 2024-02-16 to 2025-05-22. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 21,099 shares, $99,165 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 7 legs across 7 filings — 28,009 shares, $519,430 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 17.
- Largest priced transaction: sale of 7,132 shares @ $29.84 ($212,805) in ROCKET PHARMACEUTICALS, INC., filed 2024-02-21.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| ROCKET PHARMACEUTICALS, INC. (RCKT) | See Remarks | 10 | 1 leg · 21,099 sh · $99,165 | 7 legs · 28,009 sh · $519,430 | 17 |
Form 4 filings — Patel Kinnari
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2025-05-22 | 4 | ROCKET PHARMACEUTICALS, INC. (RCKT) | Sale (S): 767 @ $6.45 | EDGAR |
| 2025-05-20 | 4 | ROCKET PHARMACEUTICALS, INC. (RCKT) | Sale (S): 1,409 @ $6.53 | EDGAR |
| 2025-04-10 | 4 | ROCKET PHARMACEUTICALS, INC. (RCKT) | Purchase (P): 21,099 @ $4.70 | EDGAR |
| 2025-02-25 | 4 | ROCKET PHARMACEUTICALS, INC. (RCKT) | Sale (S): 6,078 @ $10.58 | EDGAR |
| 2025-02-13 | 4 | ROCKET PHARMACEUTICALS, INC. (RCKT) | Grant/award (A): 57,786 @ $0 · Grant/award (A): 172,214 (derivative) @ $0 | EDGAR |
| 2024-11-25 | 4 | ROCKET PHARMACEUTICALS, INC. (RCKT) | Sale (S): 4,588 @ $13.05 | EDGAR |
| 2024-08-20 | 4 | ROCKET PHARMACEUTICALS, INC. (RCKT) | Sale (S): 3,989 @ $18.50 | EDGAR |
| 2024-05-20 | 4 | ROCKET PHARMACEUTICALS, INC. (RCKT) | Option exercise (M): 3,990 @ $0 · Option exercise (M): 5,553 @ $0 · Other (J): 11,970 @ $0 · Other (J): 52,489 @ $0 · Other (J): 38,735 @ $0 · Sale (S): 4,046 @ $23.35 · +5 more | EDGAR |
| 2024-02-21 | 4 | ROCKET PHARMACEUTICALS, INC. (RCKT) | Sale (S): 7,132 @ $29.84 · Grant/award (A): 33,288 @ $0 · Grant/award (A): 98,183 (derivative) @ $0 | EDGAR |
| 2024-02-16 | 4 | ROCKET PHARMACEUTICALS, INC. (RCKT) | Option exercise (M): 26,189 @ $0 · Option exercise (M): 3,990 (derivative) @ $0 · Option exercise (M): 22,199 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1725929 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →